Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, WOM, MAT

Shady Grove Fertility (SGF) to Host Donor Egg Treatment Informational Seminar in London, 3 November 2019 at the Grosvenor House Hotel


WASHINGTON, Oct. 21, 2019 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF), a leader in reproductive medicine, will be hosting a complimentary patient seminar in the UK to discuss their renowned International Donor Egg Program. Shady Grove Fertility Founder and UK Program Director, Michael J. Levy, M.D. will outline the donor egg treatment process and discuss the specifics about this integrated program that allows patients to access exceptional services provided locally by multiple, local clinics and the donor egg registry available only at SGF.

Among the many benefits of SGF's program, couples and individuals choose a medically, genetically, and psychologically prescreened egg donor who is ready to cycle and donate, without the wait. While SGF's donor registry de-identifies the donors, the donor registry provides prospective recipients (the intended parents) with a wealth of information about the donor, including, in many cases, adult photos.

SGF, a pioneer in offering an IVF treatment financial guarantee for donor egg, makes treatment affordable through their exclusive Shared Donor Egg Program and Shared Risk 100% Refund Program for Donor Egg Treatment. With an IVF treatment guarantee, participants take home a baby or receive a 100% refund. Combined, these two programs offer patients up to six donor egg cycles for one flat amount at a 40 percent savings. SGF's Donor Egg Program provides patients with a highly effective treatment to overcome infertility, with a 60 percent clinical pregnancy rate per embryo transfer.

Amanda Segal, SGF's International Patient Liaison, will be onsite in London to discuss the benefits, success rates, and financial affordability of SGF's program. Attendees of the free seminar will learn about traveling abroad for treatment, with only two trips required. In addition, former SGF patients will share their experience and journey to parenthood through this unique program.

The event will take place on 3 November 2019 at 18:00 (6 PM ? 8 PM) at the Grosvenor House, a JW Marriott Hotel, Burlington Suite. 86-90 Park Lane, London W1K 7TN. Register for the seminar to learn more.

"We feel so fortunate to have found Dr. Levy. He is a wonderfully gifted doctor and so very calm and reassuring throughout the process. We are currently 5 months pregnant and have had such a positive experience with SGF," shared a former Dr. Levy patient.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

*Some exclusions apply

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: